Evidence map›Paper›PMID 36760719›Full record

ArticleOpen medicine (Warsaw, Poland)2023

Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer.

Lihui Zhang, Yunli Gao, Yue Li, Xinying Li, Haixia Gong

Open access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lihui ZhangDepartment of Anesthesiology, Hulunbeier Municipal People's Hospital (Hulunbuir Hospital Affiliated to Suzhou University Hulunbuir), Inner Mongolia, China.
Yunli GaoDepartment of Anesthesiology, Maanshan People's Hospital, Maanshan, Anhui, China.
Yue LiDepartment of Anesthesiology, Hulunbeier Municipal People's Hospital (Hulunbuir Hospital Affiliated to Suzhou University Hulunbuir), Inner Mongolia, China.
Xinying LiDepartment of Anesthesiology, Hulunbeier Municipal People's Hospital (Hulunbuir Hospital Affiliated to Suzhou University Hulunbuir), Inner Mongolia, China.
Haixia GongDepartment of Anesthesiology, First Affiliated Hospital of Nanchang University, No. 17 Yongwaizhengjie Street, Donghu District, Nanchang, Jiangxi Province, 330006 China.
Hulunbuir University · CNFirst Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Propofol, an intravenous anesthetic agent, exerts an anti-tumor peculiarity in multifarious tumors. Circular RNA hsa_circ_0000735 (circ_0000735) is involved in non-small cell lung cancer (NSCLC) progression. The purpose of this study is to investigate whether propofol can curb NSCLC progression via regulating circ_0000735 expression. Cell viability, proliferation, apoptosis, and invasion were detected using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 5-ethynyl-2'-deoxyuridine, flow cytometry, and transwell assays. Evaluation of protein levels was performed using western blotting or immunohistochemistry. Detection of circ_0000735 in tissue samples and cells was carried out using a real-time quantitative polymerase chain reaction. The molecular mechanisms associated with circ_0000735 were predicted by bioinformatics analysis and verified by dual-luciferase reporter assays. The relationship between propofol and circ_0000735

Indexed as

circ_0000735ITGB1NSCLCpropofol

Identifiers

PMID36760719
PMCPMC9896166
OpenAlexW4318713340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.